Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irofulven in Metastatic Breast Cancer
NCT00003796Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 1999
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irofulven in breast cancer, sponsored by National Cancer Institute. Started May 1999; status: completed.
02
Drugs
irofulven
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003796.